These are this Monday’s top analyst upgrades, downgrades and initiations.
Amazon.com Inc. (NASDAQ: AMZN) has seen two analyst upgrades: Wedbush raised its rating to Outperform from Neutral and raised its target to $575 from $435, and Cowen raised its rating to Outperform from Market Perform and lifted the price target to $565 from $435.
Clovis Oncology Inc. (NASDAQ: CLVS) was reiterated as Buy at Goldman Sachs, but the firm added it to the prized Conviction Buy List with a $110 price target (versus an $87.06 close).
Glaukos Corp. (NYSE: GKOS) saw its analyst quiet period end and was started as follows: Cantor Fitzgerald at Buy, Goldman Sachs at Neutral, JPMorgan at Overweight and William Blair at Outperform.
Hertz Global Holdings Inc. (NYSE: HTZ) was started as Outperform at Credit Suisse with a $23 price target (versus a $19.01 close) and reiterated as Reduce at Morgan Stanley, despite last week’s gains.
Peabody Energy Corp. (NYSE: BTU) was maintained as Buy but the price target was cut to $6 from $9 at Citigroup. This was after an 8% drop to $1.29 on Friday.
Whiting Petroleum Corp. (NYSE: WLL) was raised to Positive from Neutral with a price target of $33.00 (versus a $26.47 close) at Susquehanna. Shares were indicated up over 1% at $26.80 on Monday morning.
ALSO READ: Why Bank of America and Citigroup Book Value Discount Matters
Yelp Inc. (NYSE: YELP) was downgraded to Equal Weight from Overweight at Barclays, and the price target was cut to $36 from $50 in the call. Shares were indicated down 1% or so from the $34.96 closing price.
Other key analyst upgrades and downgrades were in the following:
AEGON N.V. (NYSE: AEG) was raised to Buy from Hold at Jefferies.
CBS Corp. (NYSE: CBS) was downgraded to Hold from Buy at Pivotal Research.
Dunkin Brands Group Inc. (NASDAQ: DNKN) was downgraded to Underperform from Outperform at CLSA.
Epizyme Inc. (NASDAQ: EPZM) was downgraded to Neutral from Buy and the price target was slashed in half to $22 from $45 at H.C. Wainwright.
ALSO READ: How Analysts Now Are Valuing Google
FibroGen Inc. (NASDAQ: FGEN) was raised to Buy from Neutral with a $32 price target (versus a $23.21 close) at Goldman Sachs.
Genesis Energy L.P. (NYSE: GEL) was raised to Outperform from Market Perform at Wells Fargo.
Honeywell International Inc. (NYSE: HON) was reiterated as Buy and the price target was raised to $120 from $116 at Stifel.
Kinder Morgan Inc. (NYSE: KMI) was maintained as Outperform at Raymond James, but the price target was lowered to $41 from $45 in the call.
Lantheus Holdings Inc. (NASDAQ: LNTH) saw its quiet period come to an end and was started as follows: Credit Suisse at Outperform, Jefferies at Buy, RBC at Outperform and Wells Fargo at Outperform.
Scorpio Tankers Inc. (NYSE: STNG) was raised to Overweight from Neutral at JPMorgan.
Schlumberger Ltd. (NYSE: SLB) was raised to Outperform from Market Perform at Wells Fargo.
Zillow Group Inc. (NASDAQ: Z) was downgraded to Underweight from Equal Weight and the price target was cut to $70 from $90 (versus an $83.27 close) at Barclays.
In case you missed out on Friday’s top analyst upgrades and downgrades, they included of Bank of America, Google, Intel, Fairchild Semiconductor, Mobileye, National Oilwell Varco and over a dozen more companies.
Top Gaining Stocks
Top Losing Stocks